SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Charlotte Brontë — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientCharlotte Brontë
Date of birth1816-04-21
IdentifiersMRN HR-NI025-SYN-TD; SSN (made up) 000-25-3804
Document date1855-01-20
AuthorEleanor Thwaite, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

One-week review of nausea and vomiting at 8 weeks; maternal-fetal medicine consultation today. [S]

History of Present Illness

Ms. Brontë returns one week after starting doxylamine-pyridoxine, two tablets at bedtime, at 8 weeks 1 day. The bedtime dose helps her sleep, but nausea lasts most of the day and she now vomits four or five times a day. She keeps down small amounts of water, tea, and dry crackers most days and passes urine normally. She feels lightheaded only when she gets up quickly. She has stopped writing and lies down most of the afternoon. She has had no pain, bleeding, fever, or diarrhea. Her PUQE-24 score is 11 (moderate), up from 10. She weighs 44.0 kg, 4.3 percent below her pre-pregnancy weight. She saw Dr. Oyelaran-Hughes of maternal-fetal medicine this morning. [S]

ElementDetail
Interval changeWorse: vomiting four or five times a day
IntakeSmall amounts of fluid and dry food kept down most days
MedicationDoxylamine-pyridoxine two tablets at bedtime; no daytime drowsiness
PUQE-2411 (moderate), up from 10
Weight44.0 kg, 4.3 percent below her pre-pregnancy weight

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired; lightheaded only on standing quickly; no fever
GastrointestinalPositiveNausea most of the day; vomiting four or five times a day; no pain or diarrhea
GenitourinaryNegativePassing urine normally; no bleeding
PsychiatricPositiveDiscouraged but coping; no thoughts of self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Folic acid 0.4 mg oral tablet, one tablet by mouth daily (replacing an iron-containing prenatal vitamin while nausea is severe)One tablet by mouth dailyOral route1855-01-13activeS
Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, two tablets by mouth at bedtimeTwo tablets by mouth at bedtimeOral route1855-01-13 to 1855-01-20completedS
Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, one tablet in the morning, one mid-afternoon, and two at bedtime (four a day)One tablet in the morning, one mid-afternoon, and two at bedtimeOral route1855-01-20activeS
Metoclopramide 10 mg oral tablet, one tablet by mouth three times a day before mealsOne tablet by mouth three times a day, 30 minutes before mealsOral route1855-01-20 to 1855-01-29completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1855-01-20Body height152cmS
1855-01-20Body weight44kgS
1855-01-20Body mass index (BMI) [Ratio]19kg/m2S
1855-01-20Systolic blood pressure102mm[Hg]S
1855-01-20Diastolic blood pressure64mm[Hg]S
1855-01-20Heart rate92/minS
1855-01-20Respiratory rate14/minS
1855-01-20Body temperature36.8CelS
1855-01-20Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1855-01-20Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
1855-01-20Potassium [Moles/volume] in Serum or Plasma3.6mmol/L3.5-5.1 mmol/LNormalS
1855-01-20Chloride [Moles/volume] in Serum or Plasma99mmol/L98-107 mmol/LNormalS
1855-01-20Carbon dioxide, total [Moles/volume] in Serum or Plasma26mmol/L22-29 mmol/LNormalS
1855-01-20Urea nitrogen [Mass/volume] in Serum or Plasma11mg/dL6-20 mg/dLNormalS
1855-01-20Creatinine [Mass/volume] in Serum or Plasma0.58mg/dL0.4-0.9 mg/dLNormalS
1855-01-20Glucose [Mass/volume] in Serum or Plasma74mg/dL70-99 mg/dLNormalS
1855-01-20Ketones [Mass/volume] in Urine by Test strip40mg/dL<=0 mg/dLHighS

Physical Exam

Vital signs recorded on 1855-01-20; see the Vital Signs section. [S]

SystemFinding
GeneralSlight and tired; not distressed
HydrationMucous membranes slightly dry; no orthostatic drop in blood pressure; pulse 92
NeckThyroid not enlarged
AbdomenSoft and non-tender

Problems

ProblemClinical statusVerificationCodeProvenance
First pregnancy at 38 (elderly primigravida), single live intrauterine pregnancy dated by ultrasound at 7 weeks 1 dayactiveconfirmed O09.519S — Synthetic modern prenatal care anchored to the documented report that she was pregnant when she died; the pregnancy itself is questioned in one source (CLM-0019).
Nausea and vomiting of pregnancy, moderate (PUQE-24 score 10), with early weight loss, under evaluation for hyperemesis gravidarumactiveconfirmed O21.9S — Synthetic presenting concern at the index visit, superseded by the hyperemesis gravidarum diagnosis at the sick visit; her documented "perpetual nausea" is D and the hyperemesis reading of it is R.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPUQE-24 score (recorded in the note; no LOINC code found)Every visit while nausea and vomiting lastCompleted today11 (moderate), up from 10
ExaminationWeight against pre-pregnancy weight (46.0 kg), pulse, blood pressure, and hydrationEvery visit while nausea and vomiting lastCompleted today44.0 kg, down 4.3 percent; pulse 92; no orthostatic drop; mucous membranes slightly dry
LaboratoryElectrolytes, urea nitrogen, creatinine, and glucoseWhen vomiting is moderate or severe, daily while on intravenous fluids, and until stable on oral intakeCompleted todayNormal; potassium 3.6 mmol/L at the low end
LaboratoryUrine ketonesWith vomiting; recorded but not a measure of severity or dehydrationCompleted today40 mg/dL
LaboratoryTSH and free T4In hyperemesis gravidarum; repeat at 16 to 18 weeks if suppressedNot indicatedNot yet needed: no hyperemesis; to be checked if it develops
Medication safetyAntiemetic effects: drowsiness with doxylamine-pyridoxine; restlessness and abnormal movements with metoclopramideEvery visit and after each changeCompleted todayNo daytime drowsiness; metoclopramide starts today with counseling to stop it if restlessness or abnormal movements occur
LaboratoryFirst prenatal tests (blood group, antibody screen, rubella, hepatitis B, HIV, syphilis, hepatitis C, urine culture)At the first prenatal visitCompleted todayReviewed today: all normal or negative
LaboratoryInterferon-gamma release assay for tuberculosisOnce, for household tuberculosis exposureCompleted todayNegative; reviewed with her
ReferralMaternal-fetal medicine consultationEarly in a first pregnancy at 38 with worsening nausea and vomitingCompleted todaySeen today; escalation thresholds, screening, and aspirin plan agreed
SurveyAneuploidy screening choiceOffered before 10 weeksCompleted todayChose cell-free DNA from 10 weeks with a nuchal translucency scan; declined diagnostic testing unless a screen is positive
ExaminationBlood pressureEvery prenatal visitCompleted today102/64 mmHg
ExaminationFetal heartEvery prenatal visit once audible by handheld Doppler (from about 10 to 12 weeks)Not indicatedNot yet reliably audible by Doppler at 8 weeks; cardiac activity was seen on the dating scan a week ago

Goal progress:

Guideline basis: ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018); The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024); Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020); Latent Tuberculosis Infection in Adults: Screening (2023)

Follow-up: Review in about three weeks, at 11 weeks, sooner by telephone or same day if the thresholds are reached. Next scheduled visit 1855-02-10: prenatal visit at 11 weeks: nausea and vomiting review and cell-free DNA screening. [S]